While tech stocks suffered in 2022, the wearable theme is tipped to benefit as people turn to technology to track health and fitness. Companies like Samsung and Apple are developing advanced devices and have recently reported earnings growth, while the share price of glucose monitoring expert Dexcom has beaten the wider market.
- Samsung and Apple are investing in new spins on wearables as the market expands in value
- Global smartwatch shipments were up 30% year-over-year in Q3 2022
- The Invesco QQQ Trust offers exposure to Apple and Dexcom
Samsung [005930.KS] and Apple [AAPL] are among companies investing heavily in a new generation of wearable fitness trackers.
A December report from ResearchandMarkets predicts the AI wearables market will grow from $17bn in 2022 at a compound annual growth rate (CAGR) of 29.87% to 2033.
While many consumers strap trackers to their wrists, more devices are being designed to collect data from other parts of our body, such as our fingers, following in the footsteps of Finnish ‘smart ring’ startup Oura. In October, Samsung filed a patent suggesting it's working on a similar design, which could include a built-in electrocardiogram (ECG) monitor.
Step-counting watches are also getting upgrades. Apple announced the launch of Apple Watch Ultra in September. The device promises to track blood oxygen, sleep, menstrual cycles, heart rate and, for swimmers, dive depth. Apple’s share price dropped 26.4% through 2022, but demand for the Ultra might drive a welcome recovery.
More niche trackers supporting specific health conditions are also entering the market. The share price for Dexcom [DXCM], a company that manufactures a continuous glucose monitor for people with diabetes, rose 59.9% to the end of 2022 after a stock split last June.
Wearable sales rising steadily
Apple has led the trend for wearable devices since the launch of Apple Watch in 2015. For the fourth quarter (Q4) of 2022, Apple reported revenues up to $90.1bn, an increase of 8% year-over-year, and diluted earnings per share (EPS) of $1.29, up 4% year-over-year.
Garmin [GRMN] and Fitbit, which was acquired by Alphabet [GOOGL] for $2.1bn in early 2021, are also major players in the space. Garmin's share price slumped 30.2% in 2022, while Fitbit parent Alphabet fell 39.1% during a difficult year for tech.
Samsung’s Galaxy Fit and Huawei’s smartwatch models are leading rivals to Apple Watch. Samsung posted record Q3 consolidated revenues last October, although throughout 2022 its share price has fallen 28.1%.
In Q3 2022, Dexcom posted revenues of $769.6m, up 20% year-over-year growth. A number of analysts have offered 12-month share price target increases for the stock in recent months. Citigroup, in December, raised its target on the stock from $117 to $146 and gave a ‘buy’ rating.
Gen Z driving wearables revolution
New technological developments are opening the door for devices and apps to become all-round health companions. Consumer demand appears to be increasing alongside innovation, with the latest data from Counterpoint Research showing that global smartwatch shipments rose 30% year-over-year during Q3 2022.
According to ResearchandMarkets’ report on artificially intelligent (AI) wearables, rapid adoption of wearables is driven by willingness among millennials and Gen Z to use smartwatches, alongside the rise of AI, 5G smartphones and the Internet of Things (IoT).
The fitness tracking industry is a multi-billion-dollar market as more players enter the fray. A 2021 analysis from Allied Market Research estimated wearable fitness tracker market to be worth $38.7bn in 2020, with the potential to hit $124.3bn by 2028 as motivation to collect more personal health and wellbeing data increases.
A more recent report by Facts and Factors in April 2022 estimated that the global wearable technology market would reach $380.5bn by 2028, growing at a CAGR of 18.5%.
Funds in focus: Invesco QQQ Trust
There are no ETFs dedicated solely to wearable health and fitness technology at present, though this could well change in the future as the market expands further.
At present, ETFs offering exposure to some names in this expanding field include the Invesco QQQ Trust [QQQ]. As of 3 January, Apple has a 11.39% share of its portfolio, making it the second-largest holding and Dexcom currently has limited exposure with only a 0.41% weighting. Fitbit parent Alphabet Class A and C shares also feature in the portfolio’s top 10 holdings, with respective weightings of 3.86% and 3.89%. The fund is down by 32.8% over the past 52 weeks.
Dexcom is the largest holding in the GlobalX Internet of Things ETF [SNSR], where it has 8.55% of the portfolio as of 3 January. The fund also offers exposure to Garmin stock, which is the fourth-largest holding at 5.17%. In the past 52 weeks, SNSR has declined by 24.8%.
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.